България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
-
Introduction

Introduction

What is subcutaneous infusion and where is Neria™ indicated?

Subcutaneous infusion continuously delivers medication over a longer period - in the fatty tissue beneath the skin.

On this page:  Indications    FAQ's

Subcutaneous infusion continuously delivers medication over a longer period into fatty tissue beneath the skin, where the body absorbs it. A needle penetrates the skin, leaving either the needle or a soft catheter in the tissue for up to 72 hours.

Needles and cannulas can vary in length, size, features and method of insertion. Using an infusion set for continuous subcutaneous infusion requires fewer injections (insertions) compared to injection therapy.

  1. Infusion pump
  2. Tubing
  3. Infusion set with needle and adhesive

The specific treatment set-up and type of medication is always determined by a healthcare professional.

Palliative care

Pain management is an important part of end of life care for individuals with serious illnesses where the aim is to improve quality of life. (1)

Parkinsons

Parkinson’s disease is a movement disorder of the nervous system that worsens over time. Certain treatments can be administered subcutaneously to provide a steady level of medication in the body. (2)

Immunodeficiencies

Subcutaneous infusion can deliver immunoglobulin (antibodies) under the skin to treat immunodeficiencies, which refers to a group of either inherited (primary immunodeficiencies) or acquired disorders that prevent the body’s immune system from working properly. (3)

Thalassemia

A heterogeneous group of blood disorders that affect haemoglobin, thalassemia results in iron overload and can be treated using iron chelating drugs delivered subcutaneously. (4)

2. Our devices

Neria™

Get to know our infusion sets

A basic infusion set includes an insertion needle, adhesive pad, tubing and a luer-lock connector. The specific features of each Neria™ infusion set vary, and the right set will depend on your preferences and your patient’s treatment needs.

On this page: Components    How to use    Compare Real stories    FAQ’s

Your choice for simplifying subcutaneous infusion

The Neria™ infusion sets are designed and approved for subcutaneous infusion in the treatment of diseases such as Parkinson’s disease, thalassemia, primary immune deficiency and pain management.*

*Convatec IC, data on file, D012-002912, 2023.

Neria™ infusion sets offer:

  • Thin needles (G27)
  • Built-in adhesive
  • Double-layer, small bore tubing to minimise drug waste and priming volumes*
  • Reduced risk of needle stick injury (with Neria™ Guard)*
  • Tubing disconnect at the infusion site on Neria™ Guard and Neria™ Soft
  • Standard luer-lock connection

 

 

 

 

Watch the demonstration video

Follow this simple step-by-step guide when using the Neria™ Guard automatic inserter.

“The Convatec Neria™ Guard infusion set has transformed my insulin delivery experience. Its reliable adhesive and flexible design provide unmatched comfort and security. I feel confident knowing my medication is delivered effectively.”


Dr Emily Carter, Clinical Specialist

“The Convatec Neria™ Guard infusion set has transformed my insulin delivery experience. Its reliable adhesive and flexible design provide unmatched comfort and security. I feel confident knowing my medication is delivered effectively.”


Dr Emily Carter, Clinical Specialist

3. Techniques

Techniques

How to select and manage infusion sites

The following guidance can help you find the best places to insert an infusion set and how to rotate the insertion site to minimise any potential skin irritation.(1)(2)

On this page: Techniques    Troubleshooting    Test your knowledge    FAQ’s

Site selection: choosing the right placement

Typical insertion sites are on your lower back, abdomen, hips, buttocks, thigh or upper arm. Consider also cannula length when selecting the optimal insertion site for your patient.

Insertion tips:

  • Make sure the site is clean and dry.
  • Avoid sites in contact with constrictive clothing, such as a waistband, or other objects that can pull on the infusion set.
  • Avoid the navel and surrounding area.
  • Do not select a site that is infected, swollen, red, irritated, bruised or bleeding.
  • Do not insert in an area with lumps, hard tissue or bumps.
  • Do not insert into bone or muscle as this may cause pain, damage the product
    and affect medication absorption.

Site rotation: best practices and rotation patterns

It is important to not re-use the same insertion site:

  • Use a pattern, such as a clock or snake, to guide the next insertion site placement.
  • Choose a site that is at least 2.5 cm away from the previous site.*
  • Leave the site to rest and do not re-use until the skin has healed.

Remember, the above rotation pattern is an example only. Consult local guidelines
and select the rotation pattern that works best for the individual patient.

*IEADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management, Diabetes Therapy, (2019) 10:341-366

Site management: managing infusion over time

  • Remember to visually inspect the infusion set and site several times each day.
  • Follow recommended hygiene procedures and ensure the site remains clean and dry.
  • Change the infusion set as per drug indication.
  • Do not use any creams, oils or perfumes on the site.
  • Gently massage the site after use.
  • If nodules occur, consider ultrasound treatment. (Henriksen, Tove, and Harry Staines. “Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease: A Single- Center, Long-Term Follow-Up Study of the Causes for iscontinuation.” Journal of personalized medicine vol. 11,6 525. 8 Jun. 2021.)
4. Patient support

Patient support

Equip your patients with knowledge and confidence

The following guidance can help you explain subcutaneous infusion to patients and answer their most common questions.

On this page: Everyday situations  Common questions

Wearing an infusion set doesn’t have to hold your patients back, but it’s important to take precautions to avoid issues like dislodgement or skin irritation.

a man playing basketball ;

Avoid placing the infusion set in a high friction area or in an area with repeated muscle movements. Sweat, movement or impact may dislodge the set or cause irritation.

a person with the arms crossed ;

It’s generally safe and beneficial to stay as active as possible but always make recommendations based on the specific needs of the patient and as assessed by the healthcare professional.

a man smiling outside ;

Neria™Guard and Neria™Soft allow for disconnection of the tubing and pump, prior to taking a bath or shower.

a pink flower in a black basket ;

Patients can shower and bathe while wearing the infusion set. However, If the adhesive tape becomes loose, change to a new product and a new site. Check the insertion site frequently to ensure that the soft cannula or needle remain firmly in
place. If it is not in place, change to a new product and a new site.

a faucet on a tile wall ;

Disconnect the infusion pump and tubing (for Neria™ Guard and Neria™ Soft only) before taking a bath or shower and make sure to check the site before reconnecting.

a woman in a pool ;

When choosing an infusion set, consider the patient’s activity level. An infusion set with a disconnect option at site makes it easier for the patient to shower and engage in sports. Consider the availability of custom bags for carrying the pump during activities.

close-up of a man wearing glasses ;

The tubes that come with the infusion sets vary in length. Consider which length is most convenient for the patient and offers the right level of mobility.

a woman and an old man ;

When travelling, carry infusion sets in hand baggage in case of a delay and remember to carry spare sets.

a person walking in a large room with large screens ;

Before going through security, disconnect the pump and inform security staff about the infusion pump.

a man and woman embracing ;

Consider the availability of custom bags for carrying the pump during holiday activities such as hiking and cycling.

a man and woman in a car ;
5. Knowledge centre

Knowledge Centre

Download Fact Cards

Subscribe to stay in the know

Newsletter sign up

Contact Details

Contact Details

Work Details

Work Details

We need your consent to continue

We need your consent to continue

Consent to Data Processing
Consent to Marketing

You can manage your consent at any time by unsubscribing through a link in our emails, contacting us at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com.

You can manage your consent at any time by unsubscribing through a link in our emails, contacting us at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com.

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?